//This biotech firm received $483 million from the US to make a coronavirus vaccine. It has never brought a product to market before.
CNN

This biotech firm received $483 million from the US to make a coronavirus vaccine. It has never brought a product to market before.

Podcast | Timeline | Catch up | Where states stand on reopening